Harmony Biosciences Holdings, Inc. Quarterly Stockholders' Equity Attributable to Parent in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Harmony Biosciences Holdings, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2018 to Q2 2024.
  • Harmony Biosciences Holdings, Inc. Stockholders' Equity Attributable to Parent for the quarter ending June 30, 2024 was $539M, a 11% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $539M +$53.4M +11% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $515M +$72.4M +16.3% Mar 31, 2024 10-Q 2024-08-06
Q4 2023 $467M +$64.2M +15.9% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $481M +$137M +40% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $485M +$239M +96.8% Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $443M +$229M +107% Mar 31, 2023 10-Q 2024-08-06
Q4 2022 $403M +$216M +116% Dec 31, 2022 10-Q 2024-08-06
Q3 2022 $344M +$192M +126% Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $247M +$120M +94.8% Jun 30, 2022 10-Q 2023-10-31
Q1 2022 $215M +$107M +98.8% Mar 31, 2022 10-Q 2023-08-01
Q4 2021 $187M +$89.3M +91.9% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $152M +$57.5M +60.8% Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $127M +$610M Jun 30, 2021 10-Q 2022-11-01
Q1 2021 $108M +$580M Mar 31, 2021 10-Q 2022-08-02
Q4 2020 $97.2M +$520M Dec 31, 2020 10-K 2024-02-22
Q3 2020 $94.5M +$479M Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$483M -$140M -40.7% Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$472M Mar 31, 2020 10-Q 2021-08-10
Q4 2019 -$423M -$180M -74.3% Dec 31, 2019 10-K 2023-02-21
Q3 2019 -$385M Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$344M Jun 30, 2019 10-Q 2020-11-12
Q4 2018 -$243M Dec 31, 2018 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.